BLBenjamin Daniel Lovin

Benjamin Daniel Lovin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Benjamin Daniel Lovin has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Longitudinal Impact of Radiotherapy on Osseointegrated Hearing Aid Outcomes and Complications

    by Benjamin D. Lovin, Mike Hernandez, Paul W. Gidley, Karine Al Feghali, Jack Phan, Catherine Wang, Congjun Wang, Dianna Roberts, Marc‐Elie Nader

    Objective: To evaluate the impact of radiotherapy on osseointegrated hearing aids (OIHA) complications. Methods: Retrospective review of percutaneous OIHA performed from 2006 to 2021 at an academic institution. Implant and abutment‐related complications were evaluated and stratified by radiation parameters. Main outcome measures were abutment, implant, and major complications assessed using the modified Holgers and IPS grading scales. Results: Total of 190 OIHA were included; 124 (65%) were placed in bones that previously or subsequently received radiation. Total of 84 (44%) OIHA experienced at least one complication at mean 43.3 months. Radiation cohort had greater rates of having any complication ( p = 0.032), major complication ( p = 0.014), implant complication ( p = 0.007), and abutment complication ( p = 0.032). IPS score distribution was significantly different between groups ( p = 0.011). Subgroup analysis of periauricular skin and parotid tumors demonstrated a significant association between any complication and abutment size ( p = 0.005) and length of follow‐up ( p < 0.001) on logistic regression. Notably, every 1 mm increase in abutment size decreased the risk of any complication by 23%, and every 1‐year increase in follow‐up increased the risk of any complication by 67%. There was a trend toward more implant and abutment complications with higher radiation doses. Cumulative incidence plots demonstrate a greater discrepancy in complication rates between groups as time increases. Conclusion: Radiation significantly increases the risk of both abutment and implant‐related OIHA complications, particularly in the long term. Ongoing surveillance for complications in this population is critical. The IPS grading scale may be more sensitive for cataloging complications. Increasing the abutment size and decreasing radiation dosages may decrease complications. Level of Evidence: 3.


  • Comparative Analysis of Vestibular Dysfunction and Compensation in Ramsay‐Hunt Syndrome and Vestibular Neuritis

    by Benjamin D. Lovin, Jeffrey T. Vrabec

    Objective: To investigate vestibular loss and compensation in Ramsay‐Hunt syndrome with dizziness (RHS‐D) and vestibular neuritis (VN).Study Design: Retrospective cohort study from 2019 to 2023.Setting: Tertiary care neurotology practice.Methods: Patients with RHS‐D or VN who underwent videonystagmography, including cervical vestibular evoked myogenic potential (cVEMP), caloric stimulation, rotary chair, and oculomotor testing, were reviewed and stratified by vertigo etiology. The main outcome measures were rates and severity of vestibular loss, as measured by cVEMP and caloric stimulation, and of vestibular compensation, as measured by rotary chair and oculomotor testing.Results: Ten patients were found to have RHS‐D and 22 with VN. Caloric and cVEMP abnormalities were noted in 100 and 70% of RHS‐D patients compared to 60 and 20% with VN (P = .029 and P = .034, respectively). RHS‐D patients were significantly more likely to present with concurrent caloric and cVEMP abnormalities compared to VN (70 and 13%, respectively; P = .009). Vestibular loss appeared more severe in RHS‐D compared to VN suggested by significantly lower mean bithermal slow phase velocity sum (3.8 and 21 degrees per second, respectively), greater canal paresis (78.7 and 40.2%, respectively), and greater cVEMP amplitude asymmetry (64 and 31%, respectively) (P = .014, P < .001, and P = .053, respectively). Regarding vestibular compensation, abnormal gain asymmetry was present in 88% of RHS‐D patients with a mean asymmetry of 31.2 compared to 11% in VN with a mean of 14.0 (P = .019 and P = .003, respectively).Conclusion: Compared to VN, RHS‐D patients appear to suffer from a more profound vestibular loss and a worsened ability to compensate for such deficits.


  • Quality of Life After Pediatric Tympanomastoidectomy

    by Benjamin D. Lovin, Aaron C. Nguyen, Nathan R. Lindquist, Duc Nguyen, Rodrigo Silva, Alex D. Sweeney

    Objectives: To assess quality of life (QOL) outcomes after canal wall up (CWU) and canal wall down (CWD) tympanomastoidectomy in the pediatric population. Methods: A retrospective review tabulated pediatric patients undergoing CWU and CWD tympanomastoidectomy for cholesteatoma by 2 senior surgeons at a single tertiary academic referral center between March 2017 and March 2023. Chronic Ear Survey (CES) and cosmetic survey outcomes were collected post-operatively. Results: A total of 77 ears in 75 patients were identified, with 35 undergoing CWU and 42 undergoing CWD as the most recent (index) otologic surgery. Seventeen patients (23%) participated in the survey. Of this cohort, the mean age was 14.6 years, 12 (71%) were male, and 10 (59%) had CWD as the most recent otologic surgery. The mean time from index surgery to survey completion was 3.4 years (range, 0.1-6.7 years). Regarding QOL outcomes, there were no statistically significant differences in total CES score, CES subscores, and cosmetic survey scores between groups when categorizing by gender or index surgery. Total CES, symptom subscale, medical resource subscale, and cosmetic survey scores showed a tendency to decrease with an increasing number of surgeries ( R = −.18, −.28, −.53, and −.56, respectively). Pediatric total CES scores appeared comparable to those reported in the published adult literature. Conclusions: It does not appear that there are worse QOL outcomes for pediatric patients who undergo CWD tympanomastoidectomy compared to those who undergo CWU tympanomastoidectomy. There appears to be no difference in QOL outcomes between pediatric and adult patients undergoing tympanomastoidectomy.

  • Losartan May Not Prevent Vestibular Schwannoma Growth or Related Hearing Loss During Observation

    by Benjamin D. Lovin, Marc-Elie Nader, Yun Qing, Mike Hernandez, Shaan Raza, Franco DeMonte, Paul W. Gidley

    Objective: To evaluate the impact of losartan on vestibular schwannoma (VS) growth and related hearing loss during observation. Study design: Retrospective cohort study Setting: Tertiary referral center Patients: Sporadic VS patients undergoing initial observation with at least two magnetic resonance imaging and audiologic examinations. Intervention: Losartan Main Outcome Measures: Endpoints included VS growth, quantitative audiologic changes, survival free of tumor growth, and survival free of nonserviceable hearing. Patient characteristics and endpoints were compared by losartan use. Results: Seventy-nine patients were included, of which 33% were taking losartan. Tumor growth was observed in 50% of patients in the losartan group and 36% in the non-losartan group (p = 0.329). Survival analysis failed to show a significant difference in the hazard rate of VS growth between groups (hazard ratio, 1.38; 95% confidence interval, 0.70–2.70; p = 0.346). Throughout observation, mean decreases in normalized pure-tone average were 5.5 and 9.3 dB in the losartan and non-losartan groups, respectively (p = 0.908). Mean decreases in normalized word recognition score were 11.0 and 16.6% in the losartan and non-losartan groups, respectively (p = 0.757). Nonserviceable hearing developed in 19% of patients in the losartan group and 28% in the non-losartan group (p = 0.734). Survival analysis did not demonstrate a significant difference in the hazard rate of developing nonserviceable hearing between groups (hazard ratio, 1.71; 95% confidence interval, 0.56–5.21; p = 0.337). Conclusions: Losartan use may not reduce the risk of VS growth or hearing loss during observation. A randomized trial would be ideal to further identify the true effect on growth and hearing.


  • Vestibular Hypofunction Screening in Older Cochlear Implant Candidates

    by Benjamin D. Lovin, Daniel Gorelik, Kenny F. Lin, Jeffrey T. Vrabec

    Objective: Vestibular loss is associated with increasing age and hearing loss. Cochlear implantation (CI) may be performed in these patients; however, CI can induce vestibular hypofunction (VH) postoperatively. If CI is performed in the “better balancing ear,” patients may experience vestibulopathy from new bilateral VH. The objective of this study was to evaluate the rates of VH in older CI candidates, thereby helping to identify patients at increased risk for bilateral VH after CI.Study Design: Retrospective cohort study from 2019 to 2022 of patients age 60 to 80 years old who underwent videonystagmography (VNG).Setting: Tertiary care neurotology practice.Methods: VNG, including spontaneous nystagmus, cervical vestibular evoked myogenic potential (cVEMP), caloric stimulation, and rotary chair, was reviewed and stratified by CI candidacy. Patients with prior CI or known vestibular diagnosis were excluded.Results: Thirty‐three patients were CI candidates and 184 patients were controls. cVEMP demonstrated a significantly greater rate of unilateral VH in CI candidates (P = .018). Caloric stimulation demonstrated an elevated rate of bilateral VH and presbyvestibulopathy in CI candidates (P = .057 and P = .036, respectively). Rotary chair demonstrated a significantly higher rate of bilateral VH and incomplete vestibular compensation based on reduced gain and gain asymmetry, respectively, in CI candidates (P < .001 and P = .043, respectively). Mean bithermal slow phase velocity sum and rotary chair gain were significantly lower in the CI candidate group (P = .002 and P < .001, respectively). Preoperative identification of VH determined the side of implantation in 4 patients (15%).Conclusion: VH and incomplete vestibular compensation are common and more frequently seen in CI candidates compared to age‐matched controls. Vestibular screening can play a role in surgical counseling and planning, and should be considered in older patients undergoing CI.


  • Open Access

    Case Report: Contralateral Progression of a Vestibular Schwannoma After Resection in a Patient with Neurofibromatosis Type 2

    by Ihika Rampalli, Collin William English, Tyler Lazaro, Benjamin Daniel Lovin, Sungho Lee, Andrew Tsao Huang, Ali Jalali, Kathleen Kelly Gallagher, Jacob J. Mandel, Alex Daniel Sweeney, et al.

    BACKGROUND AND IMPORTANCE: Bilateral vestibular schwannomas (VS) are a distinctive feature of neurofibromatosis type 2 (NF2) that result in a serious reduction in the quality of life for patients. The growth rates of these schwannomas are variable, and the early detection of increased growth is fundamental for improving outcomes. CLINICAL PRESENTATION: A 17-year-old man with NF2 and bilateral VS presented with complete right facial paralysis and sudden right hearing loss less than 1 month after resection of a left VS. Imaging revealed rapid growth of the right VS with intratumoral hemorrhage, and the patient underwent urgent surgical resection with some improvement in symptoms. DISCUSSION: Existing literature indicates a similar phenomenon after a longer post-operative period; however, none have shown such rapid symptomatology. Multiple etiologies were explored for this presentation, including the sudden decompression from the primary resection, paracrine factors, and hypervascularity from prior radiation. CONCLUSION: VS resection in a patient with NF2 may be followed by rapid growth in the contralateral VS, leading to severe symptom presentation. Patients should be counseled regarding this risk to enable early detection and intervention.

  • Isolated Fracture of the Malleus: An Overlooked Cause of Conductive Hearing Loss?

    by Benjamin D. Lovin, Joshua Cody Page, Eric N. Appelbaum, Daniel Gorelik, Kenny F. Lin, Jeffrey T. Vrabec

    Objective: To report the largest case series of isolated malleus fractures with systematic review to characterize the disease's presentation and natural history, and provide suggestions for management.Data Sources: PubMed, Embase, Cochrane Library.Review Methods: Retrospective cohort study was performed on 12 patients with isolated malleus fractures. History, physical exam, pre‐ and post‐treatment audiograms, and imaging were obtained. Systematic review of the literature was performed.Results: Including the cases herein, 58 isolated malleus fractures were identified, the majority of which were published in the 21st century. Mean time to presentation after injury was 34.4 months. Most common etiology was external auditory canal (EAC) manipulation. Physical exam and imaging did not identify any abnormality at presentation in 16% and 21% of cases, respectively. The majority of fractures involved the manubrium. Air‐bone gap (ABG) at initial presentation ranged from 16 to 26 dB, and was greater at higher frequencies. Thirty‐six cases underwent surgery. ABG improvement was greater at all frequencies for those who underwent surgery. Final ABG was significantly less than initial ABG at nearly every frequency for those who underwent surgery (p < 0.05), while not at any frequency for those who were observed.Conclusions: Isolated malleus fractures may occur more often than historical data suggests, and are perhaps underdiagnosed. Abrupt removal of a finger from the EAC with pain and hearing loss is nearly pathognomonic. Conductive hearing loss with ABG greater at higher frequencies is most often observed. Observation is unlikely to produce spontaneous improvements in hearing, while surgery demonstrates reliable decreases in ABG. Laryngoscope, 134:1032–1041, 2024


  • The Effect of Metformin on Vestibular Schwannoma Growth: A Systematic Review and Meta‐analysis

    by Benjamin D. Lovin, Alex J. Wilkinson, Yun Qing, Mike Hernandez, Marc‐Elie Nader, Shaan Raza, Franco DeMonte, Paul W. Gidley

    ObjectivesTo systematically review and evaluate metformin's potential impact on vestibular schwannoma (VS) growth. Data SourcesPubMed, Cochrane Library, and Embase. Review MethodsA retrospective cohort study was performed on sporadic VS patients undergoing initial observation who had at least two magnetic resonance imaging studies. Patients were stratified by metformin use during the observation period. Primary endpoint was VS growth, defined as at least a 2 mm increase in diameter. Survival free of tumor growth was evaluated between groups. Systematic review and meta-analysis were performed to produce a pooled odds ratio [OR]. Study heterogeneity was assessed and post-hoc power analysis was performed. ResultsA total of 123 patients were included, of which 17% were taking metformin. Median patient age was 56.6 years (range, 25.1-84.5). There were no statistically significant differences between the groups. Survival analysis did not demonstrate a statistically significant difference in time to VS growth between groups (hazard ratio = 0.61, 95% confidence interval [CI] = 0.29-1.29). Furthermore, logistic regression analysis did not demonstrate a statistically significant difference between groups in the odds of VS growth (OR = 0.46, 95% CI = 0.17-1.27). Systematic review identified 3 studies. Meta-analysis suggested that metformin reduces the odds of developing VS growth (pooled OR = 0.45, 95% CI = 0.29-0.71). Studies demonstrated low between-study heterogeneity. Power analysis demonstrated a sample size of 220 patients with equal randomization would be required to prospectively identify a true difference with 80% power. ConclusionsMetformin use may reduce the odds of VS growth. A randomized trial would be ideal to identify an unbiased estimate of metformin's effect on VS growth. Laryngoscope, 2023


  • Imaging of Alternobaric Facial Palsy: An Etiologic Hypothesis

    by Benjamin D. Lovin, Joshua Cody Page, Jeffrey T. Vrabec

    Objective: To report a case of alternobaric facial palsy (AFP) with a hyperpneumatized temporal bone and to review the relevant literature in order to propose a new facet of AFP pathogenesis. Methods: A patient with a hyperpneumatized temporal bone was found to have recurrent episodes of facial palsy associated with air travel. Systematic review of PubMed, Cochrane Library, and Embase characterized all articles related to transient facial palsy associated with altitude changes or diving with a focus on demographics and imaging findings. Results: A 25 year-old male was referred for recurrent facial palsy associated with commercial air travel. Imaging demonstrated a hyperpneumatized and well-aerated temporal bone. Total air cell volume was calculated to be 8.59 cc on the affected side. A systematic review of the literature identified 49 cases of AFP. Mean age was 34 years old and 80% were male. Twelve cases had imaging of the temporal bone for evaluation, of which 85% demonstrated at least 1 area of hyperpneumatization. Hyperpneumatization was most frequently encountered in the mastoid, zygomatic root, and inferior petrous apex. Conclusion: Hyperpneumatization of the temporal bone is critical to AFP etiology as it predicts higher middle ear pressure, if atmospheric pressure changes cannot be equilibrated, via reduced efficacy of normal tympanic membrane pressure buffering. This hypothesis helps to better account for the rarity of the condition and male preponderance.


  • Effects of Age on Delayed Facial Palsy After Otologic Surgery: A Systematic Review and Meta-Analysis

    by Benjamin D. Lovin, Alex D. Sweeney, Alyssa Claire Chapel, Kristan Alfonso, Nandini Govil, Yi-Chun Carol Liu

    To report 4 cases of delayed facial palsy (DFP) after pediatric middle ear (ME) surgery and systematically review and analyze the associated literature to evaluate the effects of age on DFP etiology, management, and prognosis. Systematic review of PubMed, Cochrane Library, and Embase for articles related to DFP after cochlear implantation (CI) was performed. These articles were assessed for level of evidence, methodological limitations, and number of cases. Meta-analysis was performed to assess the effects of age on DFP incidence. Furthermore, a comprehensive list of all pediatric DFP cases after otologic surgery was assembled through a multi-institutional retrospective review and systematic review of the literature. Twenty-nine articles fit the criteria for inclusion in the meta-analysis. The incidence of DFP after CI was 0.23% and 1.01% for pediatric and adult cases, respectively. This difference was statistically significant (P < .001, odds ratio 4.36). Twenty-three cases, adding to the 4 presented herein, were suitable for a comprehensive list. The mean age was 6.9 years. Average postoperative day of paresis onset was 5.4, with an average maximum House–Brackmann grade of 3.5. All patients obtained full facial recovery after an average of 23.5 days. The systematic review demonstrates that DFP after pediatric CI is rare and occurs at a significantly lower rate than in adults, further supporting the viral reactivation hypothesis of DFP. The prognosis for pediatric DFP after otologic surgery is excellent, with a high rate of full recovery in a short time frame. However, steroid administration can be considered. IIa